Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
11.99
+0.03 (+0.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
Is Now The Time To Buy Stock In Novavax, Zoom Or Workhorse?
February 25, 2022
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...
Via
Benzinga
Novavax: The Frustration Is Real, And So Is the Sales Potential
February 25, 2022
All isn't well with NVAX stock, but it is very close to rallying. The results could give Novavax a boost and push the stock high.
Via
InvestorPlace
Novavax Is a Buy on Recent Developments and Cheap Valuation
February 24, 2022
NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years.
Via
InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
February 24, 2022
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Novavax Stock’s Wild Moves Leave Little Room for Error
February 22, 2022
NVAX stock can still bring profits for traders and investors as long as they are willing to accept the risks that it brings.
Via
InvestorPlace
Why I’m Done With Novavax Stock
February 15, 2022
Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock.
Via
InvestorPlace
Novavax Whale Trades Spotted
February 09, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 11 strange trades.
Via
Benzinga
Production Updates Could Give Novavax Stock a Big Boost
February 22, 2022
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.
Via
InvestorPlace
Check Out What Whales Are Doing With NVAX
February 22, 2022
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
After Being Unloved on Wall Street, Novavax Deserves a Shot
February 22, 2022
NVAX stock was a darling of the markets once and could be again, given Novavax's recent progress in advancing Covid-19 vaccines globally.
Via
InvestorPlace
Why Novavax Has Limited Downside from Here
February 21, 2022
As countries potentially adopt a once yearly vaccination booster schedule for Covid-19, you can expect steady earnings for NVAX stock.
Via
InvestorPlace
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
February 21, 2022
NVAX stock's price continues to slide lower as the prospects of its Covid-19 vaccine getting approved in the U.S. grow dim.
Via
InvestorPlace
Novavax's COVID-19 Vaccine Scores Canadian Approval
February 17, 2022
Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older. The vaccine, also known as NVX-...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
Macy's Inc (NYSE:M) retail stores have something for everyo...
Via
Benzinga
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying.
Via
InvestorPlace
Novavax Just Can’t Get it Together
February 16, 2022
Patient investors will wait for NVAX stock to hit another low or for the FDA to approve its Covid-19 vaccine before investing.
Via
InvestorPlace
Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not
February 15, 2022
NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax.
Via
InvestorPlace
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage.
Via
InvestorPlace
52 Biggest Movers From Yesterday
February 15, 2022
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...
Via
Benzinga
What Are Whales Doing With Novavax
February 14, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades.
Via
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 14, 2022
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60...
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate...
Via
Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study
February 11, 2022
Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged...
Via
Benzinga
Novavax Stock Is a Buy After This Overdone Sell-Off
February 09, 2022
NVAX stock dropped too sharply on a negative Reuters article about Novavax, creating a great buying opportunity for investors.
Via
InvestorPlace
The Resumption Of Negotiations Between The U.S. And Iran May Lead To Lower Oil Prices
February 09, 2022
The US stock indices closed on the plus side on Tuesday.
Via
Talk Markets
51 Biggest Movers From Yesterday
February 09, 2022
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.